Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Amwell (NYSE: AMWL) announced a public offering of 11,280,647 shares of its Class A common stock at a price of $27.50 per share, led by certain stockholders. The offering includes a 30-day option for underwriters to purchase an additional 1,692,097 shares. Notably, Amwell will not receive any proceeds from this offering. The transaction is expected to close on January 20, 2021, subject to customary conditions. The offering is led by Morgan Stanley, Goldman Sachs, Piper Sandler, and UBS Investment Bank, with the registration statement effective since January 14, 2021.
Amwell (NYSE: AMWL) announced the commencement of its public offering roadshow, involving the sale of 11,280,647 shares of Class A common stock by certain Selling Stockholders. An additional 1,692,097 shares may be purchased by underwriters. Amwell will not receive proceeds from this offering, which is led by Morgan Stanley and Goldman Sachs. A registration statement has been filed with the SEC, pending effectiveness. This move highlights Amwell's focus on expanding its telehealth services, which already connect over 80 million lives.
Amwell (NYSE: AMWL) has announced the launch of Amwell Psychiatric Care, a new telepsychiatry solution aimed at hospitals and health systems to address the escalating demand for behavioral healthcare in the U.S. This service offers 24/7 access to board-certified psychiatrists and seeks to improve patient throughput in emergency departments. Asana Integrated Medical Group, part of Amwell since 2019, has received The Joint Commission's Gold Seal for Behavioral Healthcare Accreditation, reinforcing Amwell's commitment to quality care in the mental health sector.
Amwell (NYSE: AMWL) announced new leadership appointments, with Egbert van Acht as Executive Vice Chairman and Frank McGillin as CEO. This joint venture with Cleveland Clinic aims to enhance digital health services, especially in telemedicine, which has surged during the COVID-19 pandemic. The company focuses on offering high-acuity care via its MyConsult platform, supporting over 2,000 conditions. Both leaders bring extensive experience from global organizations, highlighting the company's strategy to leverage Cleveland Clinic's expertise and Amwell's technology for improved patient care.
Amwell (NYSE: AMWL) announced the participation of Ido Schoenberg and Keith Anderson in the 32nd Annual Piper Sandler Virtual Healthcare Conference from December 1-3, 2020. They will engage in a fireside chat on December 3 at 1:00 p.m. EDT. A live audio webcast, along with a replay, will be accessible on Amwell's investor relations website for approximately 90 days following the presentation.
Amwell is a leading telehealth platform, empowering over 2,000 hospitals and 55 health plan partners. The company connects providers and patients, delivering affordable, high-quality healthcare.
Amwell, a telehealth leader (NYSE: AMWL), announced its Q3 2020 financial results, showing significant growth amid increased telehealth demand. Total active providers surged to ~62,000, with total visits reaching ~1.41 million, up from 255,000 YOY. Total revenue was $62.6 million, compared to $34.7 million last year, driven by strong subscription and visit revenues. However, gross margin declined to 32.7% from 45.1%, and the net loss expanded to $(64.6) million from $(24.1) million. The company expects full-year revenue between $235 and $239 million.
Amwell (NYSE: AMWL) has announced new telehealth products including Amwell Now, Touchpoint Tablet software, and the C500 telemedicine cart to enhance virtual care delivery amid the ongoing COVID-19 pandemic. These offerings aim to simplify and integrate telehealth services for healthcare providers and patients, improving accessibility and efficiency. Amwell Now provides quick video visit capabilities, while the Touchpoint software enables bedside video connectivity. The C500 cart features advanced technology for remote exams, supporting diverse healthcare specialties.
Amwell (NYSE: AMWL) has achieved full URAC Accreditation in Telemedicine, reinforcing its commitment to quality virtual care during the ongoing pandemic. This independent accreditation, awarded for the second time, showcases Amwell's adherence to URAC's rigorous standards for safety, privacy, and quality in healthcare delivery. Ido Schoenberg, Co-CEO of Amwell, emphasized that this accreditation ensures their clients and patients can trust in their telehealth services. URAC's President highlighted the significance of this achievement in promoting value-based care access amidst rapid changes in the telehealth industry.
Amwell (NYSE: AMWL) will report its Q3 operating results on November 12, 2020, following which a live conference call will take place at 5:00 p.m. ET. Investors can access the audio webcast through investors.amwell.com. Amwell is a leading telehealth provider, offering services to over 2,000 hospitals and 55 health plans, covering more than 80 million lives. The company believes in transforming healthcare through digital care delivery and provides comprehensive telehealth solutions.
Amwell (NYSE: AMWL) has announced the appointment of Ms. Deborah C. Jackson to its Board of Directors, effective immediately. With over 30 years of leadership experience, Jackson currently serves as President of Cambridge College and previously was CEO of the American Red Cross of Eastern Massachusetts. Ido Schoenberg, Co-CEO, expressed confidence in Jackson's ability to offer valuable insights as the company transitions into a new growth phase in digital health. Amwell, a leader in telehealth, connects providers and patients while aiming to expand access to affordable healthcare solutions.
FAQ
What is the current stock price of American Well (AMWL)?
What is the market cap of American Well (AMWL)?
